Durability of immune responses to the BNT162b2 mRNA vaccine

• Published in: Med (New York, N.Y. : Online) Vol. 3; no. 1; pp. 25 - 27
• Main Authors: Suthar, Mehul S., Arunachalam, Prabhu S., Hu, Mengyun, Reis, Noah, Trisal, Meera, Raeber, Olivia, Chinthrajah, Sharon, Davis-Gardner, Meredith E., Manning, Kelly, Mudvari, Prakriti, Boritz, Eli, Godbole, Sucheta, Henry, Amy R., Douek, Daniel C., Halfmann, Peter, Kawaoka, Yoshihiro, Boyd, Scott D., Davis, Mark M., Zarnitsyna, Veronika I., Nadeau, Kari, Pulendran, Bali
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 14.01.2022
• Subjects: Antibody Formation; BNT162 Vaccine; COVID-19 - prevention & control; COVID-19 Vaccines; Humans; mRNA Vaccines; Vaccines, Synthetic

Antibody responses to the Pfizer-BioNTech mRNA vaccine waned substantially 6 months after the second vaccination. Substantial waning of antibody responses to the Pfizer-BioNTech mRNA vaccine 6 months after the second vaccination.